Main > > >CORONARY REVASCULARIZATION. *

Cardio.>Coronary Artery Disease. Chronic Total Occlusion (CTO). ReCanalization. MicroCatheter.
USA Approval Date: 2017. 10.26.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.09.




Cardio.>HyperTriGlyceridemia. (HTG). Icosapent Ethyl [Ethyl EicosaPentaenoic Acid (E-EPA)]. Indications:
Indication (1): HTG>Treat.>Diet+ Icosa-
pent Ethyl Capsules.
Indication (2): CardioVascular (CV)
Events (in Adult Pa-
tients with HTG & CV
DIS. or Diabetes) RISK
Reduction: Statin+Icosa-
pent Ethyl Capsules.
CV Events:
- Coronary Revascularization.
- Myocardial Infarction (MI)
- Stroke
- Unstable Angina requiring hospitali-
zation.
CA Approval Date (2): 2020. 01.02.
USA Approval Date (1): 2012.
USA Approval Date (2): 2019. 12.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.03.


>CORONARY REVASCULARIZATION. *'s products
This section has no products